Retraction notice to “Angiotensin receptor blockade improves the net balance of cardiac Ca2+ handling-related proteins in sympathetic hyperactivity-induced heart failure” [Life Sci. 88/13-14 (2011) 578–585, (S0024320511000294), (10.1016/j.lfs.2011.01.009)];Angiotensin receptor blockade improves the net balance of cardiac Ca 2+ handling-related proteins in sympathetic hyperactivity-induced heart failure

Life Sciences

Volumn 88, Issue 13-14, 2011, Pages 578-585

  Ferreira, Julio C B ^a   Moreira, Jose B N ^a   Campos, Juliane C ^a   Pereira, Marcelo G ^a   Mattos, Katt C ^a   Coelho, Marcele A ^a   Brum, Patricia C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiac remodeling; Neurohumoral activation; Protein kinase A; Renin angiotensin system; Ventricular dysfunction

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; LOSARTAN; PHOSPHATASE; PHOSPHATASE 1; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; COMPUTER AIDED DESIGN; CONGENIC STRAIN; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; MALE; MORPHOLOGY; MORPHOMETRICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SYMPATHETIC HYPERACTIVITY; SYMPATHETIC TONE; WESTERN BLOTTING; WILD TYPE;

MUS;

EID: 79952708917     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2024.122603     Document Type: Erratum

References (39)

1. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Ca2+/calmodulin- dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res 2005;97:1314-22.
2. Bacurau AV, Jardim MA, Ferreira JC, Bechara LR, Bueno Jr CR, Alba-Loureiro TC, et al. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training. J Appl Physiol 2009;106:1631-40.
3. Barki-Harrington L, Luttrell LM, Rockman HA. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 2003;108:1611-8. (Pubitemid 37187789)
4. Bartholomeu JB, Vanzelli AS, Rolim NP, Ferreira JC, Bechara LR, Tanaka LY, et al. Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure. J Mol Cell Cardiol 2008;45:240-9.
5. Brum PC, Kosek J, Patterson A, Bernstein D, Kobilka B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 2002;283:H1838-45.
6. Brum PCR, N. P., Bacrurau AV, Medeiros A. Neurohumoral activation in heart failure: the role of adrenergic receptors. An Acad Bras Ciênc 2006;78:485-503. (Pubitemid 44371940)
7. Bueno Jr CR, Ferreira JC, Pereira MG, Bacurau AV, Brum PC. Aerobic exercise training improves skeletal muscle function and Ca2+ handling-related protein expression in sympathetic hyperactivity-induced heart failure. J Appl Physiol 2010;109:702-9.
8. Crozier I, Ikram H, Awan N, Cleland J, Stephen N, Dickstein K, et al. Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group. Circulation 1995;91:691-7.
9. Dostal DE. The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function. Regul Pept 2000;91:1-11.
10. Ferreira JC, Rolim NP, Bartholomeu JB, Gobatto CA, Kokubun E, Brum PC. Maximal lactate steady state in running mice: effect of exercise training. Clin Exp Pharmacol Physiol 2007;34:760-5. (Pubitemid 47013489)
11. Ferreira JC, Bacurau AV, Evangelista FS, Coelho MA, Oliveira EM, Casarini DE, et al. The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Am J Physiol Regul Integr Comp Physiol 2008a;294:R26-32.
12. Ferreira JC, Inagaki K, Fajardo G, Churchill E, Budas G, Disatnik M, et al. Pharmacological βIIPKC inhibition is cardioprotective in late-stage hypertrophy and end-stage heart failure in two rat models. Circulation 2008b;118:S535.
13. Ferreira JC, Bacurau AV, Bueno Jr CR, Cunha TC, Tanaka LY, Jardim MA, et al. Aerobic exercise training improves Ca2+ handling and redox status of skeletal muscle in mice. Exp Biol Med (Maywood) 2010;235:497-505.
14. Goldsmith LA. Interactions between the sympathetic nervous system and the RAAS in heart failure. Curr Heart Fail Rep 2004;1:45-50.
15. Inagaki K, Iwanaga Y, Sarai N, Onozawa Y, Takenaka H, Mochly-Rosen D, et al. Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta. J Mol Cell Cardiol 2002;34:1377-85. (Pubitemid 35244415)
16. Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of experimental hypertension in mice. Hypertension 1996;28:1064-9. (Pubitemid 26415825)
17. Leenen FH, White R, Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol Heart Circ Physiol 2001;281:H2410-6.
18. LeWinter MM. Functional consequences of sarcomeric protein abnormalities in failing myocardium. Heart Fail Rev 2005;10:249-57. (Pubitemid 43115834)
19. Lu L, Mei DF, Gu AG, Wang S, Lentzner B, Gutstein DE, et al. Exercise training normalizes altered calcium-handling proteins during development of heart failure. J Appl Physiol 2002;92:1524-30. (Pubitemid 34670908)
20. Mace LC, Palmer BM, Brown DA, Jew KN, Lynch JM, Glunt JM, et al. Influence of age and run training on cardiac Na+/Ca2+ exchange. J Appl Physiol 2003;95:1994-2003. (Pubitemid 37310385)
21. Medeiros A, Rolim NP, Oliveira RS, Rosa KT, Mattos KC, Casarini DE, et al. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. J Appl Physiol 2008;104:103-9.
22. Meyer P, Lang MG, Flammer J, Luscher TF. Effects of calcium channel blockers on the response to endotelin-1, bradykinin and sodium nitroprusside in porcine ciliary arteries. Exp Eye Res 1995;60:505-10.
23. Mudd JO, Kass DA. Tackling heart failure in the twenty-first century. Nature 2008;451:919-28.
24. Oliveira RS, Ferreira JC, Gomes ER, Paixao NA, Rolim NP, Medeiros A, et al. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol 2009;587:3899-910.
25. Palaniyandi SS, Sun L, Ferreira JC, Mochly-Rosen D. Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res 2009;82:229-39.
26. Palermo J, Gulick J, Colbert M, Fewell J, Robbins J. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ Res 1996;78:504-9. (Pubitemid 26068965)
27. Paulino EC, Ferreira JC, Bechara LR, Tsutsui JM, Mathias Jr W, Lima FB, et al. Exercise training and caloric restriction prevent reduction in cardiac Ca2+-handling protein profile in obese rats. Hypertension 2010;56:629-35.
28. Pereira MG, Ferreira JC, Bueno Jr CR, Mattos KC, Rosa KT, Irigoyen MC, et al. Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Eur J Appl Physiol 2009;105:843-50.
29. Pitt B, Chang P, Timmermans PB. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial. Cardiovasc Drugs Ther 1995;9:693-700.
30. Pogwizd SM, Bers DM. Na/Ca exchange in heart failure: contractile dysfunction and arrhythmogenesis. Ann NY Acad Sci 2002;976:454-65. (Pubitemid 36126930)
31. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001;88:1159-67. (Pubitemid 34132516)
32. Qing G, Garcia R. Chronic captopril and losartan (DuP 753) administration in rats with high-output heart failure. Am J Physiol 1992;263:H833-40.
33. Rolim NP, Medeiros A, Rosa KT, Mattos KC, Irigoyen MC, Krieger EM, et al. Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure. Physiol Genomics 2007;29:246-52. (Pubitemid 47173296)
34. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-14.
35. Schwinger RH, Hoischen S, Reuter H, Hullin R. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts. J Mol Cell Cardiol 1999;31:283-96. (Pubitemid 29078238)
36. Sweet CS, Rucinska EJ. Losartan in heart failure: preclinical experiences and initial clinical outcomes. Eur Heart J 1994;15(Suppl D):139-44.
37. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4. (Pubitemid 9256559)
38. Vanzelli AS, Medeiros A, Sirvente Rde A, Salemi VM, Mady C, Brum PC. Association of physical training with beta-blockers in heart failure in mice. Arq Bras Cardiol 2010;95:373-80.
39. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G, et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005;11:409-17. (Pubitemid 40562331)